Lynparza 50 mg hard capsules | License Info | AstraZeneca Pharmaceuticals (Ireland) DAC

Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Olaparib
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/14/959/001

50 milligram(s)

L01XX46

Capsule, hard

Product Notice

Reminder: Lynparza 50 mg Hard Capsules have been discontinued. It is expected that stock will be depleted by December 2021.